# Serum level of (interleukin (IL)-2, IL-10, tumor necrosis factor (TNF)-a, motilin (MTL), gastrin (GAS), pepsinogen (PG), after adjunctive treatment in patients with chronic atrophic gastritis

**Authors:** Pan Xue

PMC · DOI: 10.5937/jomb0-56027 · Journal of Medical Biochemistry · 2025-10-28

## TL;DR

This study shows that combining TCM matrine with omeprazole improves stomach health and reduces inflammation in patients with chronic atrophic gastritis.

## Contribution

The study demonstrates that matrine combined with omeprazole improves histopathology and gastric function in CAG patients.

## Key findings

- Patients treated with matrine and omeprazole had lower histopathological scores compared to those with omeprazole alone.
- The combination therapy reduced inflammatory cytokine levels like IL-2, IL-10, and TNF-a more effectively.
- The treatment improved H. pylori eradication rates and overall clinical efficacy.

## Abstract

The study aimed to demonstrate the impact of traditional Chinese medicine (TCM) matrine combined with omeprazole enteric-coated tablets on gastric mucosal histopathology, gastric function, inflammatory cytokines, and Helicobacter pylori (H. pylori) eradication in patients with chronic atrophic gastritis (CAG).

A retrospective collection of case data from 110 patients with CAG admitted to the TCM Department of the hospital was conducted. Patients were rolled into the test group (TG, matrine + omeprazole enteric-coated tablets) and the control group (CG, omeprazole enteric-coated tablets). The gastric mucosal histopathological scores, serological indicators (interleukin (IL)-2, IL-10, tumour necrosis factor (TNF-a), gastric function (motilin (MTL), gastrin (GAS), pepsinogen (PG)), H. pylori eradication rate, and clinical efficacy were compared.

The degree of glandular atrophy, intestinal meta-plasia, dysplasia, and inflammatory activity index in patients of TG post-treatment were lower than CG (P&lt;0.05). Post-treatment, IL-2, IL-10, and TNF-a levels in patients of TG were inferior to CG (P&lt;0.05), and the H. pylori eradication rate in patients of TG (87.27%) was inferior to CG (63.64%) (P&lt;0.05). The effective treatment rate in patients of TG post-treatment (92.73%) was higher than CG (78.18%) (P&lt;0.05).

Matrine combined with omeprazole enteric-coated tablets significantly improved gastric mucosal histopathology, reduced inflammatory cytokine levels, enhanced gastric function, and increased the H. pylori eradication rate compared to omeprazole monotherapy.

## Linked entities

- **Proteins:** mlnl (motilin-like), gastrin (gastrin/cholecystokinin-like peptide), LOC100328624 (pepsinogen II-4)
- **Chemicals:** matrine (PubChem CID 91466), omeprazole (PubChem CID 4594)
- **Diseases:** chronic atrophic gastritis (MONDO:0006665)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, MLN (motilin) [NCBI Gene 4295], IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, GAST (gastrin) [NCBI Gene 2520] {aka GAS}
- **Diseases:** dysplasia (MESH:D015792), intestinal meta-plasia (MESH:D007410), TG (MESH:D013736), inflammatory (MESH:D007249), atrophy (MESH:D001284), CAG (MESH:D005757)
- **Chemicals:** Matrine (MESH:D000093842), TG (-), omeprazole (MESH:D009853)
- **Species:** Helicobacter pylori (species) [taxon 210], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12639514/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12639514/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12639514/full.md

---
Source: https://tomesphere.com/paper/PMC12639514